Toggle light / dark theme

Largest autism genetics analysis to date uncovers more high-confidence candidates

After doubling its sample size, the largest study of genetic data from autistic people has identified 255 genes associated with the condition, an increase of more than 40 genes since the researchers’ 2019 update; 71 of the genes rise above a stringent statistical bar the team had not previously used. The new analysis also adds data from people with developmental delay or schizophrenia and considers multiple types of mutations.

“It’s a really significant step forward in what we do,” said Kyle Satterstrom, a computational biologist in Mark Daly’s lab at the Broad Institute in Cambridge, Massachusetts. Satterstrom presented the findings virtually on Tuesday at the 2021 International Society for Autism Research annual meeting. (Links to abstracts may work only for registered conference attendees.)

The team’s previous analyses used data from the Autism Sequencing Consortium, which enrolls families through their doctors. The researchers mainly scoured the genetic data to find rare, non-inherited mutations linked to autism.

Have scientists found the key to beating prostate cancer?

Researcher Professor Johann de Bono said: ‘There’s a lot of evidence that prostate cancer causes what we call immune tolerance — that the cancer suppresses the body from attacking it with its immune cells.


Scientists have discovered that a key protein may be the secret to treating prostate cancer patients with ‘miracle’ immunotherapy drugs.

Clinical trials have now begun – with the goal of unleashing cancer-killing white blood cells to attack the tumour.

Immunotherapies have had stunning results against some types of the disease.

A stretchable and suturable fiber sensor to monitor biomechanical tissue strain

Implantable electronics are among the most promising healthcare technologies, as they can help to remotely monitor specific biological processes associated with a patient’s health. While researchers have developed a variety of implantable devices over the past decade or so, existing technologies have several limitations that can prevent their widespread use in clinical settings.

The first factor preventing the large-scale implementation of existing implantable technologies is the structural mismatch between these devices and most organs/tissues in the body, which typically have complex 1D or 3D structures. Secondly, reliably fixing soft electronic devices on organs that are moving or pulsating has so far proved to be highly challenging.

Researchers at Daegu-Gyeongbuk Institute of Science & Technology (DGIST) in South Korea and ETH Zürich have recently developed a new fiber-based strain-sensing device that could overcome the limitations of existing implantable electronics. This sensor, presented in a paper published in Nature Electronics, comprises a capacitive fiber strain sensor with an inductive coil for wireless readout.

People who live past 105 years old have genes that stop DNA damage

People who reach a very old age may have their genes to thank. Genetic variants that help to prevent DNA mutations and repair any that do occur have been found in supercentenarians and semi-supercentenarians – people who reach the ages of 110 and 105, respectively.

“DNA repair mechanisms are extremely efficient in these people,” says Claudio Franceschi at the University of Bologna in Italy. “It is one of the most important basic mechanisms for extending lifespan.”

Founder of Forever Healthy doubles down on mission to accelerate rejuvenation biotechnology

That’s good funding.


Berlin, Gerrmany — Michael Greve, founder of the Forever Healthy Foundation and owner of Kizoo Technology Ventures, announced today that he will make available an additional €300 million to be invested in rejuvenation biotech.

The funds, to be deployed via Kizoo, will be used to create and support more startups in the rejuvenation space. They will also allow Kizoo to maintain a strong commitment to its key startups during follow-up rounds and to advance the therapies from clinical development to public availability.

With this €300 million commitment, Michael Greve and Kizoo double down on their mission to accelerate the advent of rejuvenation biotechnology by doing lighthouse investments in entirely new, repair-based approaches that treat the root causes of aging and thus overcome age-related diseases. Through the creation of successful companies, they seek to inspire scientists, investors, and the general public by demonstrating that human rejuvenation is not science fiction anymore and that the resulting therapies are affordable and uncomplicated.

For First Time Ever, Scientists Create Part-Human, Part-Monkey Embryos

The human cells grew inside all 132 of the embryos after just 24 hours. After ten days, 103 chimeric embryos remained. By day 19, however, only three chimeras were left alive – and they were then terminated.

“This knowledge will allow us to go back now and try to re-engineer these pathways that are successful for allowing appropriate development of human cells in these other animals,” Juan Carlos Izpisua Belmonte, genetics professor at the Salk Institute for Biological Sciences in La Jolla, California and co-author of the study, told NPR.

“We are very, very excited,” he added.

New device can measure glucose in sweat with the touch of a fingertip

Many people with diabetes endure multiple, painful finger pricks each day to measure their blood glucose. Now, researchers reporting in ACS Sensors have developed a device that can measure glucose in sweat with the touch of a fingertip, and then a personalized algorithm provides an accurate estimate of blood glucose levels.

According to the American Diabetes Association, more than 34 million children and adults in the U.S. have diabetes. Although self-monitoring of blood glucose is a critical part of diabetes management, the pain and inconvenience caused by finger-stick blood sampling can keep people from testing as often as they should.

The researchers made a touch-based sweat glucose sensor with a polyvinyl alcohol hydrogel on top of an electrochemical sensor, which was screen-printed onto a flexible plastic strip. When a volunteer placed their fingertip on the sensor surface for 1 minute, the hydrogel absorbed tiny amounts of sweat. Inside the sensor, glucose in the sweat underwent an enzymatic reaction that resulted in a small electrical current that was detected by a hand-held device.